John Y. M. Koo, MD, FAAD
SESSIONS
F054 Psychocutaneous Disease: Treating the Difficult Patient
Mar 29, 2026
•
1:00 PM - 3:00 PM
•
Mile High 1D
DISCLOSURES
AbbVie – Speaker(Honoraria); Amgen – Advisory Board(Honoraria), Speaker(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Bristol-Myers Squibb – Speaker(Honoraria); Dermavant Sciences, Inc. – Speaker(Honoraria); Eli Lilly and Company – Speaker(Honoraria); Galderma – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Speaker(Honoraria); Leo Pharma Inc. – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Speaker(Fees); Regeneron – Speaker(Honoraria); Sanofi – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Speaker(Honoraria); UCB – Speaker(Honoraria);